Large, nonplateauing relationship between clinical disability and cerebral white matter lesion load in patients with multiple sclerosis

Archives of Neurology

Volumn 69, Issue 1, 2012, Pages 89-95

  Caramanos, Zografos ^a   Francis, Simon James ^a   Narayanan, Sridar ^a   Lapierre, Yves ^b   Arnold, Douglas Lorne ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRAIN DAMAGE; CEREBRAL WHITE MATTER LESION LOAD; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DISABILITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NERVOUS SYSTEM PARAMETERS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; WHITE MATTER;

ANALYSIS OF VARIANCE; CEREBRAL CORTEX; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS; NERVE FIBERS, MYELINATED; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 84855570866     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2011.765     Document Type: Article

References (32)

1. Compston A, Coles A. Multiple sclerosis. Lancet. 2002;359(9313):1221- 1231. (Pubitemid 34304266)
2. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50(1):121-127.
3. Peterson JW, Trapp BD. Neuropathobiology of multiple sclerosis. Neurol Clin. 2005;23(1):107-129, vi-vii. (Pubitemid 40126917)
4. Li DK, Zhao G, Paty DW. T2 hyperintensities: findings and significance. Neuroimaging Clin North Am. 2000;10(4):717-738, ix. (Pubitemid 32391264)
5. Barkhof F, Karas GB, van Walderveen MA. T1 hypointensities and axonal loss. Neuroimaging Clin North Am. 2000;10(4):739-752, ix. (Pubitemid 32391265)
6. Sormani MP, Rovaris M, Comi G, Filippi M. A reassessment of the plateauing relationship between T2 lesion load and disability in MS. Neurology. 2009; 73(19):1538-1542.
7. Goodin DS. Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: have we been overly harsh in our assessment? Ann Neurol. 2006;59(4):597-605.
8. Sharrack B, Hughes RA, Soudain S, Dunn G. The psychometric properties of clinical rating scales used in multiple sclerosis. Brain. 1999;122(pt 1):141-159. (Pubitemid 29046280)
9. Hobart J, Freeman J, Thompson A. Kurtzke scales revisited: the application of psychometric methods to clinical intuition. Brain. 2000;123(pt 5):1027-1040. (Pubitemid 30224198)
10. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology. 1983;33(11):1444-1452. (Pubitemid 14237132)
11. Kurtzke JF. Natural history and clinical outcome measures for multiple sclerosis studies: why at the present time does EDSS scale remain a preferred outcome measure to evaluate disease evolution? Neurol Sci. 2000;21(6):339-341.
12. Barkhof F. MRI in multiple sclerosis: correlation with Expanded Disability Status Scale (EDSS). Mult Scler. 1999;5(4):283-286. (Pubitemid 29405626)
13. Zivadinov R, Leist TP. Clinical magnetic resonance imaging correlations in multiple sclerosis. J Neuroimaging. 2005;15(4 suppl):10S-21S. (Pubitemid 43010528)
14. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum; 1988.
15. Li DK, Held U, Petkau J, et al; Sylvia Lawry Centre for MS Research. MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability. Neurology. 2006;66(9):1384-1389. (Pubitemid 43739648)
16. Fisniku LK, Brex PA, Altmann DR, et al. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain. 2008;131 (pt 3):808-817. (Pubitemid 351294716)
17. Rovaris M, Filippi M. Contrast enhancement and the acute lesion in multiple sclerosis. Neuroimaging Clin North Am. 2000;10(4):705-716.
18. Sled JG, Zijdenbos AP, Evans AC. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging. 1998; 17(1):87-97. (Pubitemid 128742012)
19. Collins DL, Neelin P, Peters TM, Evans AC. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr. 1994;18(2):192-205. (Pubitemid 24100002)
20. Francis SJ. Automatic Lesion Identification in MRI of Multiple Sclerosis Patients [unpublished Master's thesis] .Montreal, Quebec: Division of Neuroscience, McGill University; 2004.
21. Twork S, Wiesmeth S, Spindler M, et al. Disability status and quality of life in multiple sclerosis: non-linearity of the Expanded Disability Status Scale (EDSS). Health Qual Life Outcomes. 2010;8:55.
22. Wilkinson L, Blank G, Gruber C. Desktop Data Analysis With SYSTAT. Upper Saddle River, NJ: Prentice Hall; 1996.
23. Riahi F, Zijdenbos A, Narayanan S, et al. Improved correlation between scores on the expanded disability status scale and cerebral lesion load in relapsing-remitting multiple sclerosis: results of the application of new imaging methods. Brain. 1998;121(pt 7):1305-1312. (Pubitemid 28327407)
24. Tartaglia MC, Arnold DL. The role of MRS and fMRI in multiple sclerosis. Adv Neurol. 2006;98:185-202.
25. Arnold DL. Evidence for neuroprotection and remyelination using imaging techniques. Neurology. 2007;68(22 suppl 3):S83-S91.
26. Filippi M, Agosta F. Magnetic resonance techniques to quantify tissue damage, tissue repair, and functional cortical reorganization in multiple sclerosis. Prog Brain Res. 2009;175:465-482.
27. Bakshi R, Dandamudi VS, Neema M, De C, Bermel RA. Measurement of brain and spinal cord atrophy by magnetic resonance imaging as a tool to monitor multiple sclerosis. J Neuroimaging. 2005;15(4)(suppl):30S-45S. (Pubitemid 43010530)
28. Giorgio A, Battaglini M, Smith SM, De Stefano N. Brain atrophy assessment in multiple sclerosis: importance and limitations. Neuroimaging Clin NorthAm. 2008; 18(4):675-686.
29. Caramanos Z, Narayanan S, Arnold DL. 1H-MRS quantification of tNA and tCr in patients with multiple sclerosis: a meta-analytic review. Brain. 2005;128(pt 11): 2483-2506. (Pubitemid 41552936)
30. Ropele S, Fazekas F. Magnetization transfer MR imaging in multiple sclerosis. Neuroimaging Clin North Am. 2009;19(1):27-36.
31. Rovaris M, Agosta F, Pagani E, Filippi M. Diffusion tensor MR imaging. Neuroimaging Clin North Am. 2009;19(1):37-43.
32. Santos AC, Narayanan S, de Stefano N, et al. Magnetization transfer can predict clinical evolution in patients with multiple sclerosis. J Neurol. 2002;249(6): 662-668. (Pubitemid 34651745)